QQ客服 官方微博 反馈留言

	MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3 beta/E-cadherin pathway
	Wu, Ying; Wang, Jiping; Wang, Shuyang; Zhu, Hongguang; Zhou, Chunxian; Cui, Fengyun; Li, Jiali; Wang, Diyi; Wei, Yingze
刊名	ONCOTARGET
	2017
卷号	8期号:30
关键词	non-metastatic colorectal cancer prognosis biomarker microRNA AKT pathway
ISSN号	1949-2553
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3642134
专题	上海中医药大学
推荐引用方式 GB/T 7714	Wu, Ying,Wang, Jiping,Wang, Shuyang,et al. MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3 beta/E-cadherin pathway[J]. ONCOTARGET,2017,8(30).
APA	Wu, Ying.,Wang, Jiping.,Wang, Shuyang.,Zhu, Hongguang.,Zhou, Chunxian.,...&Wei, Yingze.(2017).MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3 beta/E-cadherin pathway.ONCOTARGET,8(30).
MLA	Wu, Ying,et al."MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3 beta/E-cadherin pathway".ONCOTARGET 8.30(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。